Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism
Author(s) -
Françis Couturaud,
Olivier Sanchez,
Gilles Pernod,
Patrick Mismetti,
P. Jégo,
E Duhamel,
Karine Provost,
Claire Bal dit Sollier,
Émilie Presles,
Philippe Castellant,
Florence Parent,
PierreYves Salaün,
Luc Bressollette,
Michel nt,
Philippe Lorillon,
Philippe Girard,
Karine Lacut,
Marie Guégan,
Jean-Luc Bosson,
Silvy Laporte,
Christophe Leroyer,
Hervé Decousus,
Guy Meyer,
Dominique Mottier
Publication year - 2015
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2015.7046
Subject(s) - medicine , pulmonary embolism , vitamin k antagonist , warfarin , placebo , hazard ratio , randomization , randomized controlled trial , surgery , venous thrombosis , thrombosis , atrial fibrillation , confidence interval , alternative medicine , pathology
The optimal duration of anticoagulation after a first episode of unprovoked pulmonary embolism is uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom